Covid-19 Treatment Developer Humanigen Files for Bankruptcy
Wall Street Journal
California-based company says FDA’s rejection of lenzilumab is a major cause of its financial troubles.
https://www.wsj.com/articles/covid-19-treatment-developer-humanigen-files-for-bankruptcy-9c4772fb